An in-depth look to DIAMYD MEDICAL AB SER. B operating, investing, and financing activities

DMYD_B free cash flow for Q4 24 is -29.75 M SEK. For 2024, DMYD_B free cash flow was -137.21 M SEK and operating cash flow was -129.18 M SEK.